[{"id":"1d10a79c-1aeb-47d8-b359-538633c036e2","acronym":"","url":"https://clinicaltrials.gov/study/NCT01918254","created_at":"2021-01-18T08:39:09.173Z","updated_at":"2025-02-25T14:00:14.403Z","phase":"Phase 1","brief_title":"A Study to Evaluate Lumretuzumab in Combination With Pertuzumab and Paclitaxel in Participants With Metastatic Breast Cancer Expressing Human Epidermal Growth Factor Receptor (HER) 3 and HER2 Protein","source_id_and_acronym":"NCT01918254","lead_sponsor":"Hoffmann-La Roche","biomarkers":" HER-2 • ERBB3","pipe":" | ","alterations":" HER-2 expression","tags":["HER-2 • ERBB3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e paclitaxel • Perjeta (pertuzumab) • lumretuzumab (RG7116)"],"overall_status":"Completed","enrollment":" Enrollment 66","initiation":"Initiation: 08/06/2013","start_date":" 08/06/2013","primary_txt":" Primary completion: 10/07/2016","primary_completion_date":" 10/07/2016","study_txt":" Completion: 10/07/2016","study_completion_date":" 10/07/2016","last_update_posted":"2017-09-12"},{"id":"39b75b55-ad92-4eb5-b91c-32fcb9289773","acronym":"","url":"https://clinicaltrials.gov/study/NCT01482377","created_at":"2021-01-18T06:11:26.844Z","updated_at":"2024-07-02T16:37:26.198Z","phase":"Phase 1a/1b","brief_title":"A Study of RO5479599 Alone or in Combination With Cetuximab or Erlotinib in Participants With Metastatic and/or Locally Advanced Malignant Human Epidermal Growth Factor Receptor (HER3) Expressing Solid Tumors of Epithelial Cell Origin","source_id_and_acronym":"NCT01482377","lead_sponsor":"Hoffmann-La Roche","biomarkers":" EGFR • ERBB3","pipe":" | ","alterations":" EGFR expression • ERBB3 expression • EGFR positive","tags":["EGFR • ERBB3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EGFR expression • ERBB3 expression • EGFR positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Erbitux (cetuximab) • erlotinib • lumretuzumab (RG7116)"],"overall_status":"Completed","enrollment":" Enrollment 145","initiation":"Initiation: 12/01/2011","start_date":" 12/01/2011","primary_txt":" Primary completion: 02/01/2016","primary_completion_date":" 02/01/2016","study_txt":" Completion: 02/01/2016","study_completion_date":" 02/01/2016","last_update_posted":"2017-01-27"}]